ADMA Biologics
ADMA
ADMA
23 hedge funds and large institutions have $54.7M invested in ADMA Biologics in 2017 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 2 reducing their positions, and 5 closing their positions.
Holders
23
Holders Change
+4
Holders Change %
+21.05%
% of All Funds
0.52%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
9
Increased
10
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
PA
1
Perceptive Advisors
New York
|
$12.3M |
| 2 |
CCM
2
Consonance Capital Management
New York
|
$10.8M |
| 3 |
BC
3
Broadfin Capital
New York
|
$3.54M |
| 4 |
6CM
4
683 Capital Management
New York
|
$3.05M |
| 5 |
MWVC
5
Morgens Waterfall Vintiadis & Co
New York
|
$1.61M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| – | – | -11,673 | Closed |
|
27
UBS Group
Zurich,
Switzerland
| – | – | -3,400 | Closed |
|
28
Bank of America
Charlotte,
North Carolina
| – | – | -4 | Closed |
|